Publications

Export 38 results:
Auteur Title Type [ Année(Asc)]
Filtres: Mot-clé is Depressive Disorder, Major  [Enlever les filtres]
2020
Belzeaux R, Gorgievski V, Fiori LM, Lopez JPablo, Grenier J, Lin R, Nagy C, Ibrahim EChérif, Gascon E, Courtet P et al..  2020.  GPR56/ADGRG1 is associated with response to antidepressant treatment.. Nat Commun. 11(1):1635.
Phillips JL, Jaworska N, Kamler E, Bhat V, Blier J, Foster JA, Hassel S, Ho K, McMurray L, Milev R et al..  2020.  A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.. BMC Psychiatry. 20(1):268.
Nagy C, Maitra M, Tanti A, Suderman M, Théroux J-F, Davoli MAntonietta, Perlman K, Yerko V, Wang YChang, Tripathy SJ et al..  2020.  Single-nucleus transcriptomics of the prefrontal cortex in major depressive disorder implicates oligodendrocyte precursor cells and excitatory neurons.. Nat Neurosci. 23(6):771-781.
Uher R, Frey BN, Quilty LC, Rotzinger S, Blier P, Foster JA, Müller DJ, Ravindran AV, Soares CN, Turecki G et al..  2020.  Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 Report.. J Clin Psychiatry. 81(4)
2016
Burns RJ, Deschênes SS, Schmitz N.  2016.  Associations between coping strategies and mental health in individuals with type 2 diabetes: Prospective analyses.. Health Psychol. 35(1):78-86.
Kedzior KKarolina, Gierke L, Gellersen HMarie, Berlim M.  2016.  Cognitive functioning and deep transcranial magnetic stimulation (DTMS) in major psychiatric disorders: A systematic review.. J Psychiatr Res. 75:107-15.
Chung JKu, Plitman E, Nakajima S, Chakravarty MM, Caravaggio F, Gerretsen P, Iwata Y, Graff-Guerrero A.  2016.  Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.. J Geriatr Psychiatry Neurol. 29(3):149-59.
Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR et al..  2016.  Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.. BMC Psychiatry. 16:105.
Li W, Meng X, Xu Z, Yu Q, Shi J, Yu Y, D'Arcy C, Huang Y, Kou C.  2016.  Prevalence, correlates of major depression: A mental health survey among undergraduates at a mainland Chinese university.. Asia Pac Psychiatry. 8(3):206-14.
Sears C, Schmitz N.  2016.  The Relationship between Diabetes and Mental Health Conditions in an Aging Population.. Can J Diabetes. 40(1):4-5.
2015
Jollant F.  2015.  Add-on lithium for the treatment of unipolar depression: too often forgotten? J Psychiatry Neurosci. 40(1):E23-4.
Deschênes SS, Burns RJ, Schmitz N.  2015.  Associations between depression, chronic physical health conditions, and disability in a community sample: A focus on the persistence of depression.. J Affect Disord. 179:6-13.
Deschênes SS, Burns RJ, Schmitz N.  2015.  Associations between diabetes, major depressive disorder and generalized anxiety disorder comorbidity, and disability: findings from the 2012 Canadian Community Health Survey--Mental Health (CCHS-MH).. J Psychosom Res. 78(2):137-42.
Meng X, D'Arcy C.  2015.  Comorbidity between lifetime eating problems and mood and anxiety disorders: results from the Canadian Community Health Survey of Mental Health and Well-being.. Eur Eat Disord Rev. 23(2):156-62.
Kedzior KKarolina, Gellersen HMarie, Brachetti AKatharina, Berlim M.  2015.  Deep transcranial magnetic stimulation (DTMS) in the treatment of major depression: An exploratory systematic review and meta-analysis.. J Affect Disord. 187:73-83.
Oh G, Wang S-C, Pal M, Chen ZFei, Khare T, Tochigi M, Ng C, Yang YA, Kwan A, Kaminsky ZA et al..  2015.  DNA modification study of major depressive disorder: beyond locus-by-locus comparisons.. Biol Psychiatry. 77(3):246-55.
McGirr A, Van den Eynde F, Tovar-Perdomo S, Fleck MPA, Berlim M.  2015.  Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.. J Affect Disord. 173:216-20.
Galfalvy H, Haghighi F, Hodgkinson C, Goldman D, Oquendo MA, Burke A, Huang Y-Y, Giegling I, Rujescu D, Bureau A et al..  2015.  A genome-wide association study of suicidal behavior.. Am J Med Genet B Neuropsychiatr Genet. 168(7):557-63.
Treadway MT, Waskom ML, Dillon DG, Holmes AJ, Park MTae M, Chakravarty MM, Dutra SJ, Polli FE, Iosifescu DV, Fava M et al..  2015.  Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depression.. Biol Psychiatry. 77(3):285-94.
Maheu M, Lopez JP, Crapper L, Davoli MA, Turecki G, Mechawar N.  2015.  MicroRNA regulation of central glial cell line-derived neurotrophic factor (GDNF) signalling in depression.. Transl Psychiatry. 5:e511.
Gariépy G, Thombs BD, Kestens Y, Kaufman JS, Blair A, Schmitz N.  2015.  The Neighbourhood Built Environment and Trajectories of Depression Symptom Episodes in Adults: A Latent Class Growth Analysis.. PLoS One. 10(7):e0133603.
Godlewska BR, Near J, Cowen PJ.  2015.  Neurochemistry of major depression: a study using magnetic resonance spectroscopy.. Psychopharmacology (Berl). 232(3):501-7.
Stergiopoulos V, Cusi A, Bekele T, Skosireva A, Latimer E, Schütz C, Fernando I, Rourke SB.  2015.  Neurocognitive impairment in a large sample of homeless adults with mental illness.. Acta Psychiatr Scand. 131(4):256-68.
Whitley R, Palmer V, Gunn J.  2015.  Recovery from severe mental illness.. CMAJ. 187(13):951-2.
Chachamovich E, Kirmayer LJ, Haggarty JM, Cargo M, Mccormick R, Turecki G.  2015.  Suicide Among Inuit: Results From a Large, Epidemiologically Representative Follow-Back Study in Nunavut.. Can J Psychiatry. 60(6):268-75.

Pages